LQDA Liquidia Corp

BEARISH Impact: 5/10 144
Horizon days Filed Jun 4, 2026 Processed 10d 11h ago SEC 0001969223-26-000642
Form 144 — notice of proposed sale of securities

Price Chart

Loading chart...

Executive Summary

Venture capital firm Canaan VIII LP, a director of Liquidia Corp, filed a Form 144 on June 4, 2026, indicating intent to sell 200,000 shares of common stock with an approximate market value of $13 million. This follows heavy insider selling of $8.5M over the prior 30 days and comes amid a $5B market cap with 93% analyst bullishness, suggesting potential profit-taking by a large pre-IPO investor.

Actionable Insight

A director and major pre-IPO investor signaling a large sale after a period of heavy insider selling is a bearish signal, especially given the stock's recent run-up. Monitor for actual execution and any subsequent Form 4 filings. The 93% analyst bullishness may be at odds with insider behavior — consider taking profits or hedging exposure.

Key Facts

  • Canaan VIII LP, a director and venture capital investor, filed Form 144 to sell 200,000 shares.
  • Estimated sale value of $13 million based on current market price.
  • Shares were acquired pre-IPO on July 26, 2018, for cash, indicating a cost basis near zero.
  • Filing follows $8.5M in insider sales over the prior 30 days.
  • Liquidia has a $5B market cap and 93% analyst bullish consensus.
  • Historical calibration shows score-6/7/8 filings in this segment have only ~32% probability of positive T+20 alpha, with net negative average alpha after costs.

Financial Impact

Proposed sale of 200,000 shares valued at approximately $13 million, representing about 0.26% of market cap.

dilutioninsider selling pressure

Risk Factors

  • Form 144 is only an intent to sell; the sale may not be executed.
  • Canaan VIII LP is a venture capital fund that may be distributing shares to limited partners, not signaling fundamental deterioration.
  • Stock has strong analyst support and a large market cap, which could absorb the selling pressure.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-000642
Document: 0001969223-26-000642-index.html0001969223-26-000642
Document: 0001969223-26-000642.txt0001969223-26-000642
32 reports for LQDA
Performance horizon
82% Hit rate 9 of 11 directional calls best @ T+60▲ +70.18%Mar 5, 2026
Filters
Rows
Reports for LQDA — sortable, filterable
Type Now
Jun 11, 2026
3d ago
Institutional Cluster
BULLISH ★ 5/10
$65.50 awaiting T+1awaiting T+1$71.23 (+8.75%)
Jun 10, 2026
4d ago
144
BEARISH ★ 5/10
$65.21 awaiting T+1awaiting T+1$71.23 (−9.23%)
Jun 8, 2026
6d ago
Insider Cluster
NEUTRAL ★ 3/10
$63.94 awaiting T+1awaiting T+1$71.23 (+11.40%)
Jun 8, 2026
6d ago
CLUSTER / 8-K
NEUTRAL ★ 5/10
$63.94 awaiting T+1awaiting T+1$71.23 (+11.40%)
Jun 4, 2026
10d ago
144
BEARISH ★ 6/10
$62.76 awaiting T+1awaiting T+1$71.23 (−13.50%)
Jun 4, 2026
10d ago
144
BEARISH ★ 5/10
$62.76 awaiting T+1awaiting T+1$71.23 (−13.50%)
Jun 3, 2026
11d ago
Insider Cluster
NEUTRAL ★ 3/10
$62.54 $61.85▼ −1.10%▲ +1.50%$71.23 (+13.90%)
Jun 1, 2026
13d ago
144
NEUTRAL ★ 4/10
$58.75 $55.11▼ −6.20%▼ −6.34%$71.23 (+21.24%)
May 26, 2026
19d ago
Insider Cluster
NEUTRAL ★ 4/10
$62.03 $62.03· 0.00%▼ −0.55%$71.23 (+14.83%)
May 21, 2026
25d ago
Insider Cluster
MIXED ★ 5/10
$61.97 $60.98▼ −1.60%▼ −2.04%$71.23 (+14.94%)
Showing 10 of 32

US Market Status

Market Closed — Opens in 4h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access